TCT-389 Acute and 6-Month Clinical and Echocardiographic Outcomes of the First-In-Human Experiences with the Implantation of a Novel Catheter-based Ventricular Partitioning Device in Patients with Ischemic Heart Failure and Dilated Left Ventricle

The safety of percutaneous ventricular restoration (PVR) using a novel percutaneous LV partitioning device constructed of fluoropolymer (ePTFE) membrane stretched over a nitinol frame and developed to improve cardiac performance through reduction of LV volumes was shown to be safe in a small cohort...

Full description

Saved in:
Bibliographic Details
Published in:Journal of the American College of Cardiology 2012-10, Vol.60 (17), p.B111-B111
Main Authors: Costa, Marco, Thomas, Martyn, Ince, Hüseyin, Nienaber, Christoph, Erglis, Andrejs, Gradinac, Sinisa, Gama, Vasco, Ferreira, Rui, Mazzaferri, Ernest, Sievert, Horst, Gregoric, Igor, Davidson, Charles, Berger, Peter, Elsässer, Albrecht, Waksman, Ron, Smart, Frank, Albernathy, William, Abraham, William
Format: Article
Language:English
Subjects:
Cardiology
Cardiovascular
Clinical outcomes
Heart attacks
Heart failure
Internal Medicine
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The safety of percutaneous ventricular restoration (PVR) using a novel percutaneous LV partitioning device constructed of fluoropolymer (ePTFE) membrane stretched over a nitinol frame and developed to improve cardiac performance through reduction of LV volumes was shown to be safe in a small cohort of patients.To evaluate acute and 6-month outcomes of the pooled first-in-human (FIH Cohort A and B) and U.S. feasibility trials testing PVR using the Parachute TM device.
ISSN:0735-1097
1558-3597
DOI:10.1016/j.jacc.2012.08.417